Alstom Order Covers 153 Trains for Portugal at €1.03bn

Victoria’s state government, according to the government and Alstom, ordered 25 additional X’trapolis 2.0 electric commuter trains from Alstom under an option in the 2021 contract. The EUR 270 million deal doubles the production fleet to 50 units, with at least 60% local sourcing. Alstom says builds will occur in Victoria and the first trains entered service in May 2026.

Alstom said it won a €270 million contract from Australia’s Victorian Government to supply 25 additional X’Trapolis 2.0 electric trains. The order follows an option under a 2021 deal and raises the program total to 50 trains. Trains will be built in Victoria with a 60% local content requirement. Alstom shares were up 0.33% at EUR 16.60 in Paris.

Alstom said the Victorian Government exercised an option for 25 additional X’trapolis 2.0 electric trains, worth €270m, adding to the 25 trains under a 2021 contract. The order brings Alstom’s total fleet in Victoria to 50 trains. Alstom said the trains meet a 60% local content requirement and will be booked in FY2026/27 Q2.

Alstom reported Q1 FY2026/27 orders of €2,560 million and sales of €4,734 million, up 4.9% reported and 4.8% organic. Book-to-bill was 0.5x versus 0.9x a year earlier, with backlog €102.8 billion. Alstom cited TGV-M homologation, NJ TRANSIT Multilevel III delivery, and other project milestones, and confirmed its FY2026/27 outlook.

Wendy’s (WEN) said it closed 28 restaurants and expects to close 5% to 6% of U.S. units (about 289 to 358) in 1H 2026, with possible additional selective closures. The company reported 2Q FY2026 systemwide sales down 6.5% YoY, U.S. systemwide down 8.2%, and U.S. same-restaurant sales down 7%. Wendy’s launched a turnaround plan and withdrew its 2026 outlook.

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.